植入式心脏复律除颤器对心脏性猝死的一级预防：弥合证据差距 - Suppr | 超能文献

Primary prevention of sudden death with the implantable cardioverter defibrillator: bridging the evidence gap.

作者信息

Mark Estes N A, Saba Samir

机构信息

UPMC Heart and Vascular Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

出版信息

Eur Heart J. 2020 Sep 21;41(36):3448-3450. doi: 10.1093/eurheartj/ehaa324.

DOI:10.1093/eurheartj/ehaa324

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Primary prevention of sudden death with the implantable cardioverter defibrillator: bridging the evidence gap.植入式心脏复律除颤器对心脏性猝死的一级预防：弥合证据差距

Eur Heart J. 2020 Sep 21;41(36):3448-3450. doi: 10.1093/eurheartj/ehaa324.

2

Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.植入式心脏复律除颤器对晚期心力衰竭女性心脏性猝死一级预防的有效性：一项随机对照试验的荟萃分析。

Arch Intern Med. 2009 Sep 14;169(16):1500-6. doi: 10.1001/archinternmed.2009.255.

3

Subcutaneous implantable cardioverter defibrillator indication in prevention of sudden cardiac death in difficult clinical situations: A French expert position paper.皮下植入式心律转复除颤器在困难临床情况下预防心源性猝死的适应证：法国专家立场文件。

Arch Cardiovasc Dis. 2020 May;113(5):359-366. doi: 10.1016/j.acvd.2020.03.011. Epub 2020 Apr 22.

4

Is the clinical benefit of primary prevention implantable cardioverter-defibrillator overestimated? The role of sudden cardiac death to total mortality ratio.一级预防植入式心脏复律除颤器的临床益处是否被高估？心脏性猝死与总死亡率之比的作用。

Eur Heart J. 2020 Dec 14;41(47):4525-4526. doi: 10.1093/eurheartj/ehaa580.

5

Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators.比较单腔和双腔植入式心脏复律除颤器在预防心源性猝死中的不适当电击和其他健康结局：心血管研究网络植入式心脏复律除颤器纵向研究的结果。

J Am Heart Assoc. 2017 Nov 9;6(11):e006937. doi: 10.1161/JAHA.117.006937.

6

Primary prevention of sudden cardiac death using implantable cardioverter defibrillators.使用植入式心脏复律除颤器进行心脏性猝死的一级预防。

Europace. 2008 Sep;10(9):1034-41. doi: 10.1093/europace/eun150. Epub 2008 Jun 16.

7

Important Parameters for Implantable Cardioverter Defibrillator Selection.植入式心脏复律除颤器选择的重要参数

Card Electrophysiol Clin. 2018 Mar;10(1):145-152. doi: 10.1016/j.ccep.2017.11.015.

8

Primary prevention of sudden cardiac death: a rational approach to the use of the implantable cardioverter defibrillator.心脏性猝死的一级预防：植入式心脏复律除颤器使用的合理方法。

J Interv Card Electrophysiol. 2005 Jul;13(2):91-3. doi: 10.1007/s10840-005-0338-6.

9

Prevention of sudden cardiac death: from wearable to subcutaneous cardioverter defibrillator.心脏性猝死的预防：从可穿戴设备到皮下植入式心律转复除颤器

Minerva Cardioangiol. 2018 Feb;66(1):83-99. doi: 10.23736/S0026-4725.17.04468-1. Epub 2017 Jul 10.

10

[Prevention of sudden cardiac death and implantable cardioverter defibrillators: Understanding the competitive risk!].[心脏性猝死的预防与植入式心脏复律除颤器：理解竞争风险！]

Presse Med. 2019 Dec;48(12):1401-1405. doi: 10.1016/j.lpm.2019.09.010. Epub 2019 Nov 4.

引用本文的文献

1

Strategies for Sudden Cardiac Death Prevention.心脏性猝死的预防策略

Biomedicines. 2022 Mar 10;10(3):639. doi: 10.3390/biomedicines10030639.

2

Sacubitril/Valsartan in the Management of Heart Failure Patients with Cardiac Implantable Electronic Devices.沙库巴曲缬沙坦在伴有心脏植入式电子装置心力衰竭患者管理中的应用。

Am J Cardiovasc Drugs. 2021 Jul;21(4):383-393. doi: 10.1007/s40256-020-00448-4. Epub 2020 Oct 28.